ACRV: Acrivon Therapeutics, Inc. Stock

by  •  • Comments Off on ACRV: Acrivon Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 33.24
Enterprise Value ($M) -5.92
Book Value ($M) 160.39
Book Value / Share 5.12
Price / Book 0.21
NCAV ($M) 135.37
NCAV / Share 4.32
Price / NCAV 0.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.69
Return on Equity (ROE) -0.78

Liquidity (mrq)
Quick Ratio 11.17
Current Ratio 11.17

Balance Sheet (mrq) ($M)
Current Assets 151.33
Assets 176.35
Liabilities 15.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -89.20
Net Income -80.56

Cash Flow Statement (mra) ($M)
Cash From Operations -65.67
Cash from Investing -51.77
Cash from Financing 121.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Citadel Advisors Llc 6.00
05-01 13G/A Perceptive Advisors Llc 9.90 -42.10
07-10 13G/A Chione Ltd 17.30 -0.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 72,708 411,815 17.66
2025-05-29 187,136 564,323 33.16
2025-05-28 110,789 441,075 25.12
2025-05-27 125,645 520,088 24.16

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ADMA – ADMA Biologics, Inc. ALT – Altimmune, Inc.


Financial data and stock pages provided by
Fintel.io